CTC Bio씨티씨바이오
060590 · KOSDAQ · ₩060590 · 씨티씨바이오
- Market cap
- ₩65B
- Enterprise value
- ₩69B
- P/E
- 8.6×
- P/B
- 0.8×
- Dividend yield
- 0.0%
- ROE
- 9.5%
- Net margin
- 6.1%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−52.1% from the high
₩2,570Today: ₩2,675 – ₩2,730₩5,610
Returns
- 1W−4.8%
- 1M−12.0%
- 3M−0.6%
- 6M−31.3%
- YTD−41.9%
- 1Y−50.7%
- Volume today
- 31,439
- 0.7× the 20-day average
- Traded today
- ₩85M
- Listed shares
- 24,181,020
- EPS (12 months)
- ₩311
- Earnings yield 11.6%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 38 of 100 (50 is a normal day for this stock).
- MomentumWeak-10.6% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
CTC Bio stock overview
CTC Bio (씨티씨바이오, KRX: 060590) is listed on KOSDAQ, in the Biotech & Pharma sector. CTC Bio is a Korean pharmaceutical company with two main business segments: animal medicines and human medicines. Its shares closed at ₩2,685 on Oct 28, 2026, down 1.29% on the day, giving it a market value of ₩65B.
Key facts
- Market cap
- ₩65B
- Sector
- Biotech & Pharma
- Latest price change
- −1.29%
- As of
- Oct 28, 2026
- Main business
- CTC Bio is a Korean pharmaceutical company with two main business segments: animal medicines and human medicines.
Quick answers about CTC Bio
- What does CTC Bio do?
- CTC Bio is a Korean pharmaceutical company with two main business segments: animal medicines and human medicines. Its animal medicine products include feed additives, disinfectants and vaccines, while its human medicine products include improved and generic drugs and health functional foods, with its technologies in microbial fermentation and drug delivery applied to product development. The company sells both in the domestic market and overseas, and operates manufacturing facilities in Korea.
- What is the market cap of CTC Bio?
- The market capitalisation of CTC Bio was ₩65B at the close on Oct 28, 2026.
- Who are the largest shareholders of CTC Bio?
- According to the latest official filings, the largest reported holders are BioNote (31.74%, as of Oct 27, 2025); SDB Investment (14.62%, as of Feb 3, 2025); Pharmaresearch (10.61%, as of Oct 27, 2025).
- When is the next earnings report from CTC Bio?
- Korean companies rarely announce results dates in advance. Based on when CTC Bio filed the same report in past years, its next 3q results is expected between Nov 10, 2026 and Nov 14, 2026.
Company profile
CTC Bio is a Korean pharmaceutical company with two main business segments: animal medicines and human medicines. Its animal medicine products include feed additives, disinfectants and vaccines, while its human medicine products include improved and generic drugs and health functional foods, with its technologies in microbial fermentation and drug delivery applied to product development. The company sells both in the domestic market and overseas, and operates manufacturing facilities in Korea.
Written by AI from the company's latest annual report.
- Korean name
- 씨티씨바이오
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 조창선(단독대표이사)
- Founded
- Dec 1995
- Listed
- Feb 2002
- Listed shares
- 24,181,020
- Fiscal year ends
- Month 12
- Website
- www.ctcbio.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,372,000−0.15%
- Celltrion068270 · ₩44T₩189,800+0.64%
- Alteogen196170 · ₩16T₩223,000+2.06%
- SK biopharmaceuticals326030 · ₩5.9T₩75,200+0.40%
- Yuhan000100 · ₩5.7T₩77,300−3.38%
- HLB028300 · ₩5.4T₩40,650+1.88%
- Hanmi Pharm128940 · ₩4.7T₩369,500+5.42%
- SAM Chun Dang Pharm000250 · ₩4.5T₩190,000+1.28%
Recent filings
See all- Half-year report (Jun 2026)Aug 12, 2026
- Quarterly report (Mar 2026)May 12, 2026
- Amended: Annual general meeting resultsMar 27, 2026
- Change of Head Office LocationMar 26, 2026
- Annual general meeting resultsMar 26, 2026
Titles in Korean until English translations are added.
Also known as: CTC Bio / 씨티씨바이오 / 060590 / KRX:060590
Source: KRX statistical information